Vergent is a biotechnology company focused on “lighting up” cancer to help surgeons quickly locate and completely remove tumors during resection surgery.

Vergent Bioscience

In the Know: Healthcare News for July 22, 2024

In the Know: Healthcare News for February 5, 2024

Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery

In the Know: Healthcare News for December 18, 2023

Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer Surgeries